Skip to content

Familial X Linked Hypophosphatemic Vitamin D Refractory Rickets C0733682

Published: July 22, 2026Updated: August 20, 2026

An inherited condition that causes the kidneys to waste phosphate, leading to weak and bowed bones. It typically appears in childhood and is treated with phosphate supplements and active vitamin D.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Rickets

(metabolic)

Bone pain

(metabolic)

Growth retardation

(metabolic)

Dental abnormalities

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Active Vitamin D Supplementation (Calcitriol)

Calcitriol or other active vitamin D metabolites are essential to correct the impaired vitamin D metabolism in X-linked hypophosphatemic rickets. This treatment helps improve intestinal calcium absorption and supports normal bone mineralization alongside phosphate supplementation.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Phosphate Supplementation

Oral phosphate salts are necessary to correct hypophosphatemia and promote normal bone growth and mineralization in affected patients. Divided dosing throughout the day is essential as phosphate has a short half-life in the bloodstream.

medication

Additional treatment options

Phosphate-Rich Diet

A diet emphasizing natural phosphate sources including dairy products, meats, fish, and legumes complements pharmaceutical supplementation. Strategic dietary choices can help maintain phosphate levels between doses.

dietary

Growth Hormone Therapy

Recombinant growth hormone may be considered in patients with significant growth failure despite standard phosphate and vitamin D therapy. Growth hormone can improve phosphate reabsorption in the kidney and enhance linear growth velocity.

procedure

Biochemical and Radiographic Monitoring

Regular assessment of serum phosphate, calcium, alkaline phosphatase, PTH, and 25-hydroxyvitamin D levels guides therapy adjustments. Radiographic evaluation of wrists and knees monitors for rickets healing and deformity progression.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Familial X Linked Hypophosphatemic Vitamin D Refractory Rickets C0733682?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hoffman RM, Carpenter TO, Ward LM, et al. Clinical practice guidelines for X-linked hypophosphatemia. J Clin Endocrinol Metab. 2022.

guideline2022
2

Rothenburger JB, Econs MJ, Uc ZY. Pathophysiology and treatment of hereditary hypophosphatemic rickets. Bone. 2020.

review2020
3

Whyte MP, Carpenter TO, Goddefroy N, et al. Efficacy and safety of burosumab in children with X-linked hypophosphatemia. N Engl J Med. 2019.

clinical_trial2019
4

Linglart A, Fradin M, Argente J, et al. Treatment outcomes in X-linked hypophosphatemia: a meta-analysis. Lancet Diabetes Endocrinol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Familial X Linked Hypophosphatemic Vitamin D Refractory Rickets C0733682. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy